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fhen starting our medical careers, we invariably viewed our
ork as serving patients’ needs. Over the ensuing years,
owever, we increasingly have found ourselves responding
o additional needs: payers, legislators, regulators, auditors,
edical administrators, litigators, reformers, watchdogs,
nd even physicians from other disciplines. Most of these
takeholders want the same things we do: high-quality care
hat is accessible and affordable to all who need it. However,
ne important item has changed. Now we are being asked to
prove it.”
The American College of Cardiology (ACC) finds itself
t the hub of this evolving environment, and we are gearing
p to provide cardiologists with tested tools to accurately
easure and “prove” we deliver quality care. But measuring
ersonal performance is just not enough. If all we ever did
as use our own data as the basis for improvement, we
ould only be better than we used to be. National bench-
arking sets the bar higher.
National benchmarking, in some form, has been around
or many years, but it has not been until now that we are
eing asked—or forced in some cases—to compare our
linical practice and patient outcomes against our peers.
lthough this can be daunting and frightening, this is a step
e must take. We no longer can rely simply on “physician’s
rerogative” as the answer when there are clinical care
iscrepancies. The proof is in the data, reimbursement
ecision-makers are saying, and that data had better be
ood.
But, as we all know, not all benchmarking is created
qual. For instance, if data collection is not standardized or
udited, we are faced with a possible apples-to-oranges data
ncompatibility problem. It becomes imperative that data
oints are collected in a regulated manner, using identical
lements that are input into a single electronic “home.” The
ata are then independently analyzed in similar groupings to
roduce reliable results.
The ACC has wholeheartedly adopted this straightfor-
ard data evaluation approach with its landmark American
ollege of Cardiology-National Cardiovascular Data Reg-
stry (ACC-NCDR) (1). Although the original mission to
evelop a national benchmarking service to improve clinical
uality in catheterization labs remains steadfast, the ACC- RCDR has begun to fulfill broader roles for the nation’s
ealth care than its founders first envisioned.
In recent years, large payers, multi-system provider
roups, federal agencies, and state regulators have greatly
xpanded the scope of the ACC-NCDR’s data to measure
erformance and utilization rates; replace and/or answer
ertificate-of-need questions; promote continuous quality
mprovement; conduct post-market drug and device surveil-
ance; and track patient safety. Some of these bellwether
takeholders now mandate participation in the ACC-
CDR for their constituents and, only with the participating
acility’s expressed agreement, receive either data exports or
ustomized comparative reports of that lab’s ACC-NCDR
ggregated data.
A new area of interest has included payer-sponsored “pay
or performance” programs, where a local or regional payer
as partnered with the ACC-NCDR and the state chapter
o design and implement programs that use the registry to
rack and monitor catheterization lab performance measures
gainst targeted performance goals.
The ACC-NCDR began in 1998 as a registry designed
o standardize reporting of catheterization laboratory out-
omes so that the data could be used to feed local hospital
ontinuous quality improvement initiatives. Today, the
CC-NCDR has two registries with a third to be launched
n March at ACC.06 in Atlanta, Georgia. The first registry,
he CathPCI Registry, now counts almost 700 participating
ospitals and more than 4.5 million documented diagnostic
atheterization and percutaneous coronary intervention (PCI)
rocedures. More than 75 manuscripts and abstracts published
rom the CathPCI Registry aggregate data have offered op-
ortunities for cardiologists, hospitals, and other cardiovascular
rofessionals to better understand the risks, benefits, and
ffectiveness of present and emerging technologies em-
loyed in the cardiac catheterization laboratory (2–6).
In June 2005, the ACC-NCDR closely partnered with
he Heart Rhythm Society (HRS) to launch the ICD
egistry. This new registry meets an April 1, 2006, Centers
or Medicare and Medicaid Services (CMS) mandate to
pecifically track activity in 1,300 electrophysiology labora-
ories nationwide for implantable cardioverter-defibrillators
or the primary prevention of sudden death. The ICD
egistry will address: 1) who is receiving the device; 2) who
i
i
i
t
t
t
o
i
p
t
o
f
i
s
p
s
i
s
f
c
n
c
N
(
V
d
o
t
v
s
r
e
m
A
a
a
c
•
•
•
•
•
•
T
t
o
m
a
C
t
i
p
p
c
t
t
f
o
g
m
w
o
t
l
d
u
o
a
f
h
b
a
I
N
s
c
e
r
g
c
o
t
g
r
A
C
a
f
t
A
C
1077JACC Vol. 47, No. 5, 2006 Douglas and Brindis
March 7, 2006:1076–8 President’s Pages implanting the device; 3) what brand of device is being
mplanted and how it is programmed; and 4) what are the
n-hospital outcomes (7).
The history-making decision of the CMS speaks not only
o the robust nature of the ACC-NCDR and its seven-year
rack record of delivery high-quality benchmarking, but also
o the commitment of CMS as America’s largest purchaser
f health care to evaluate patient outcomes to best assess and
mprove care of its Medicare population. It also reflects the
ower of partnership among physician societies focused on
he same outcome: quality care for the ultimate evaluators—
ur patients. The HRS and the ACC worked side-by-side
or more than nine months to effectuate this groundbreak-
ng federal benchmarking mandate.
The current efforts of the ACC to develop a carotid
tenting and endarterectomy registry are an excellent exam-
le of working collaboratively with the CMS and similarly
ituated physician societies. In March 2005, the CMS
ssued a coverage determination statement to reimburse
elected carotid stenting procedures, but it stipulated that
acilities must collect related data on patients receiving
arotid stenting procedures. The ACC-NCDR catalyzed a
ational Carotid Artery Stenting Work Group that in-
luded representatives from the American Academy of
eurology (AAN), American Society of Neuroradiology
ASNR), Society for Vascular Surgery (SVS), Society for
ascular Medicine and Biology (SVMB), Society for Car-
iovascular Angiography and Interventions (SCAI), Society
f Interventional Radiology (SIR), and ACC. As a result of
his enlightening collaboration, the national carotid inter-
ention registry will use a novel integrated data design
uitable for all disciplines, including cardiology, neurology,
adiology, and vascular surgery. Data elements are being
specially selected to meet the CMS data collection require-
ents for coverage, while still incorporating all underlying
CC-NCDR data management processes.
All ACC-NCDR registries use standard data elements
nd definitions for patient demographics, clinical variables,
nd outcomes. Core to the ACC-NCDR are the following
ritical components:
Quarterly reports to each participating facility bench-
marking its results, including risk-adjusted mortality,
against national and peer groups;
Evidence-based data elements combined with process
and performance measures that are linked to current
ACC/American Heart Association (AHA) clinical prac-
tice guidelines;
Relationships with more than 18 certified software ven-
dors that provide systems to collect data;
ACC technical and clinical support staff to provide
expertise and training;
Access to Masters and/or PhD-level biostatisticians who
conduct analysis and reporting; and
Rigorous methods to ensure data quality and accuracy,
including an on-site audit program. Rhe ACC-NCDR appreciates our participants’ reports that
he registries’ benchmarking has helped them to identify
pportunities to improve clinical as well as financial perfor-
ance. According to our ACC-NCDR facilities, they have
ctively used a supplementary product called ACC-
athKIT, a web-based quality catheterization laboratory
ool kit developed by the ACC and the SCAI (8). Included
n ACC-CathKIT are lessons in continuous quality im-
rovement (CQI) methodology, examples of relevant CQI
rojects, such as management and avoidance of groin
omplications, and downloadable templates for catheteriza-
ion laboratory protocols and PCI pathways.
The ACC-NCDR is guided in management and scien-
ific oversight by a management board consisting of senior
ellow ACC members with backgrounds in cardiovascular
utcomes research and quality. Each ACC-NCDR registry is
uided by a scientific work group that consists of fellow ACC
embers and relevant subspecialties and other society partners
ho have expertise in the particular registry.
Although national benchmarking of catheterization
utcomes and performance measures may seem remote to
he ACC members not involved in daily catheterization
aboratory activities, overall performance measurement is
efinitely on the horizon. The ACC-NCDR has proved,
nequivocally, that national benchmarking supports each
f us as we strive to practice the right kind of medicine in
n environment that supports our work. It also can forge
riendly alliances among seemingly disparate groups that
ave an inherent interest in our practice.
There are many things we can do to support national
enchmarking, even on a small scale. We can read more
bout benchmarking and the efforts of the ACC-NCDR.
f our hospitals and facilities participate in the ACC-
CDR or any other registry, we can make certain that
taff receive the support they need to be successful. We
an become involved with our ACC state chapter and
xplore opportunities for collaborative benchmarking at a
egional level.
Furthermore, as cardiologists we must become evan-
elists for our own hospitals’ quality initiatives through
hampioning ACC-NCDR participation and identifying
pportunities for local CQI initiatives. It is our obliga-
ion to step forward now, when others are seeking our
uidance. Benchmarking undoubtedly will translate di-
ectly into dollars in a world of pay for performance.
gainst which measures should we be held accountable?
lean, unadulterated data should be collected, analyzed,
nd audited by our unbiased ACC rather than by some
or-profit third-party vendor. We must—and can— be
he masters of our own destiny.
ddress correspondence to: Dr. Pamela S. Douglas, American
ollege of Cardiology, c/o Cathy Lora, 9111 Old Georgetown
oad, Bethesda, Maryland 20814-1699.
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